Publications of C. Sievers
All genres
Journal Article (56)
2009
Journal Article
23 (7), pp. 841 - 853 (2009)
Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? Journal of Psychopharmacology
Journal Article
12 (3), pp. 177 - 185 (2009)
Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary
Journal Article
19 (3), pp. 245 - 251 (2009)
The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment. Growth Hormone & IGF Research
Journal Article
70 (3), pp. 446 - 454 (2009)
Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study. Clinical Endocrinology
Journal Article
160 (3), pp. 367 - 373 (2009)
Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. European Journal of Endocrinology 2008
Journal Article
69 (3), pp. 432 - 435 (2008)
High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clinical Endocrinology
Journal Article
158 (2), pp. 153 - 161 (2008)
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients. European Journal of Endocrinology
Journal Article
13, pp. 85 - 99 (2008)
Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. Frontiers in Bioscience 2007
Journal Article
115 (8), p. 550 - 550 (2007)
German acromegaly patients interim results from the International Observational Acromegaly Study on impact of sandostatin LAR OASIS. Experimental and Clinical Endocrinology & Diabetes
Journal Article
115 (8), p. 553 - 553 (2007)
Acute effect of the growth hormone antagonist pegvisomant injection alone and in combination with a somatostatin analogue on endogenous GH and pegvisomant levels. Experimental and Clinical Endocrinology & Diabetes
Journal Article
115 (8), p. 553 - 553 (2007)
A shifted psychopathological risk profile in acromegalic patients? Experimental and Clinical Endocrinology & Diabetes
Journal Article
40 (5), p. 250 - 250 (2007)
Acromegalic patients: more depressed, without panic? The 'endocrine psychosyndrome' of romegaly revised. Pharmacopsychiatry
Journal Article
30 (4), pp. RC9 - RC12 (2007)
Pituitary imaging abnormalities in patients with and without hypopituitarism after traumatic brain injury. Journal of Endocrinological Investigation
Journal Article
115 (Suppl. 1), pp. S49 - S50 (2007)
Associations of age-dependent IGF-1 standard deviation scores to cardiovascular diseases and risk factors: A cross-sectional study in 6,282 primary care patients. Experimental and Clinical Endocrinology & Diabetes 2006
Journal Article
155, pp. 553 - 557 (2006)
Discrepant results in the diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients with traumatic brain injury. European Journal of Endocrinology 2005
Journal Article
152 (Suppl. 1) (2005)
Mechanism of somatostatin action on POMC promoter in corticotrophinoma cells. European Journal of Endocrinology Book Chapter (4)
2017
Book Chapter
Psychiatric Disease in Hypothalamic - Pituitary Disorders. In: The PITUITARY, 4th ed. Ed., pp. 413 - 419 (Ed. Melmed, S.). ELSEVIER ACADEMIC PRESS, London (2017)
2010
Book Chapter
Transsexualität. In: Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel, pp. 319 - 324 (Ed. Lehnert, H.). Thieme, Stuttgart (2010)
2007
Book Chapter
Schwangerschaft und Postpartum. In: Kompendium Schlafmedizin, Kap. XVI-2.3, pp. 1 - 5 (Eds. Schulz, H.; Deutsche Gesellschaft für Schlafforschung und Schlafmedizin). ecomed, Landsber/Lech (2007)
2006
Book Chapter
Arzt, E.; Bronstein, M.; Guitelman, M.). KARGER, BASEL (2006)
New aspects in the diagnosis and treatment of Cushing disease. In: PITUITARY TODAY: MOLECULAR, PHYSIOLOGICAL AND CLINICAL ASPECTS, pp. 169 - 178 (Eds.